Hester Biosciences Limited has informed the Exchange regarding a press release dated January 30, 2026, titled "20260130 Press Release Q3 FY26".
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hester Biosciences has informed the stock exchange about a press release dated January 30, 2026, covering its financial results for the third quarter of FY26. The filing itself is only a notification of the press release and does not contain detailed numbers in this text. Investors should refer to the attached press release or the company's Q3 FY26 results announcement for specific revenue, profit, and other financial figures. This is a routine regulatory filing confirming that the company has shared its quarterly update with the public.
No direct impact on stock price from this notification alone; the actual impact will depend on the financial numbers and outlook disclosed in the Q3 FY26 press release and results.